Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2013

Oct 9, 2013

34129_dirs_2013-10-09_a05ed4de-7f9b-4be1-a5bb-71e966164d76.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2013-10-09

Reporting Person: Galbraith Kenneth (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series C Convertible Preferred Stock $ Common Stock (19724839) Indirect
Series D-2 Convertible Preferred Stock $ Common Stock (3833767) Indirect
Series D-2 Convertible Preferred Warrants $ Common Stock (287533) Indirect

Footnotes

F1: Each share of Series C Convertible Preferred Stock and each share of Series D-2 Convertible Preferred Stock is convertible into 0.0533 of a share of Common Stock without payment of further consideration and will automatically convert into 0.0533 of a share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.

F2: These securities are held by Ventures West 8 Limited Partnership. Kenneth Galbraith is Managing Director of Five Corners Capital, Inc., the general partner of Ventures West 8 Limited Partnership . Kenneth Galbraith disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

F3: Immediately.

F4: The warrants will expire upon the closing of the initial public offering.